Search Results - DeCataldis, G

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study

    A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II st... by Frasci, G, Nicolella, G, Comella, P, Carreca, I, DeCataldis, G, Muci, D, Brunetti, C, Natale, M, Piantedosi, F, Russo, A, Palmeri, S, Comella, G, Panza, N

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial

    Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncolo... by Frasci, Giuseppe, Lorusso, Vito, Panza, Nicola, Comella, Pasquale, Nicolella, Gianpaolo, Bianco, Andrea, DeCataldis, Giuseppe, Belli, Mario, Iannelli, Nunzio, Massidda, Bruno, Mascia, Vittorio, Comella, Giuseppe, De Lena, Mario

    Published in Lung cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Cisplatin-gemcitabine-vinorelbine (PGV) vs cisplatin-vinorelbine (PV) vs cisplatin-gemcitabine (PG) in advanced non-small cell lung cancer (NSCLC). Interim analysis of a SICOG phase III trial

    Cisplatin-gemcitabine-vinorelbine (PGV) vs cisplatin-vinorelbine (PV) vs cisplatin-gemcitabine (PG) in advanced non-small cell lung cancer (NSCLC). Interim analysis of a SICOG phas... by Comella, P., Panza, N., Nicolella, G.P., Manzione, L., Lorusso, V., Cioffi, R., Decataldis, G., Maiorino, L., Bilancia, D., Comella, G.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Gemcitabine + vinorelbine (GV) vs vinorelbine (V) alone in elderly or frail non-small cell lung cancer (NSCLC) patients. Interim analysis of a SICOG phase III trial

    Gemcitabine + vinorelbine (GV) vs vinorelbine (V) alone in elderly or frail non-small cell lung cancer (NSCLC) patients. Interim analysis of a SICOG phase III trial by Frasci, G., Lorusso, V., Panza, N., DeCataldis, G., Del Gaizo, F., Nicolella, G.P., Mascia, V., Massidda, B., Comella, G., De Lena, M.

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised Phase II trial

    Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised Phase II trial by Comella, Pasquale, Frasci, Giuseppe, Panza, Nicola, De Cataldis, Giuseppe, Cioffi, Riccardo, Curcio, Carlo, Nicolella, Dario, Micillo, Enrico, Ianniello, Giovanni P., Biondi, Edoardo, Perchard, John, Comella, Giuseppe

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: